300 related articles for article (PubMed ID: 15352098)
21. Lack of polymorphism in MUC1 tandem repeats in cancer cells is related to breast cancer progression in Japanese women.
Kawaguchi T; Takazawa H; Imai S; Morimoto J; Watanabe T
Breast Cancer Res Treat; 2005 Aug; 92(3):223-30. PubMed ID: 16155793
[TBL] [Abstract][Full Text] [Related]
22. Synthetic vaccines consisting of tumor-associated MUC1 glycopeptide antigens and bovine serum albumin.
Dziadek S; Kowalczyk D; Kunz H
Angew Chem Int Ed Engl; 2005 Nov; 44(46):7624-30. PubMed ID: 16247814
[No Abstract] [Full Text] [Related]
23. Efficient synthesis of MUC4 sialylglycopeptide through the new sialylation using 5-acetamido-neuraminamide donors.
Okamoto R; Souma S; Kajihara Y
J Org Chem; 2008 May; 73(9):3460-6. PubMed ID: 18361519
[TBL] [Abstract][Full Text] [Related]
24. Towards a fully synthetic MUC1-based anticancer vaccine: efficient conjugation of glycopeptides with mono-, di-, and tetravalent lipopeptides using click chemistry.
Cai H; Huang ZH; Shi L; Zhao YF; Kunz H; Li YM
Chemistry; 2011 May; 17(23):6396-406. PubMed ID: 21538615
[TBL] [Abstract][Full Text] [Related]
25. Nuclear magnetic resonance-based dissection of a glycosyltransferase specificity for the mucin MUC1 tandem repeat.
Brokx RD; Revers L; Zhang Q; Yang S; Mal TK; Ikura M; Gariépy J
Biochemistry; 2003 Dec; 42(47):13817-25. PubMed ID: 14636048
[TBL] [Abstract][Full Text] [Related]
26. Construction of highly glycosylated mucin-type glycopeptides based on microwave-assisted solid-phase syntheses and enzymatic modifications.
Matsushita T; Hinou H; Fumoto M; Kurogochi M; Fujitani N; Shimizu H; Nishimura S
J Org Chem; 2006 Apr; 71(8):3051-63. PubMed ID: 16599599
[TBL] [Abstract][Full Text] [Related]
27. Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity.
Irimura T; Denda K; Iida Si; Takeuchi H; Kato K
J Biochem; 1999 Dec; 126(6):975-85. PubMed ID: 10578046
[TBL] [Abstract][Full Text] [Related]
28. Synthetic glycopeptides for the development of cancer vaccines.
Liakatos A; Kunz H
Curr Opin Mol Ther; 2007 Feb; 9(1):35-44. PubMed ID: 17330400
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of a multiantigenic Tn/TF-containing glycopeptide mimic of the tumor-related MUC1 glycoprotein.
Cremer GA; Bureaud N; Piller V; Kunz H; Piller F; Delmas AF
ChemMedChem; 2006 Sep; 1(9):965-8. PubMed ID: 16952141
[No Abstract] [Full Text] [Related]
30. Thomsen-Friedenreich antigen expression in gastric carcinomas is associated with MUC1 mucin VNTR polymorphism.
Santos-Silva F; Fonseca A; Caffrey T; Carvalho F; Mesquita P; Reis C; Almeida R; David L; Hollingsworth MA
Glycobiology; 2005 May; 15(5):511-7. PubMed ID: 15604091
[TBL] [Abstract][Full Text] [Related]
31. Purification and characterization of a human pancreatic adenocarcinoma mucin.
Khorrami AM; Choudhury A; Andrianifahanana M; Varshney GC; Bhattacharyya SN; Hollingsworth MA; Kaufman B; Batra SK
J Biochem; 2002 Jan; 131(1):21-9. PubMed ID: 11754731
[TBL] [Abstract][Full Text] [Related]
32. The (2-phenyl-2-trimethylsilyl)ethyl-(PTMSEL)-linker in the synthesis of glycopeptide partial structures of complex cell surface glycoproteins.
Wagner M; Dziadek S; Kunz H
Chemistry; 2003 Dec; 9(24):6018-30. PubMed ID: 14679514
[TBL] [Abstract][Full Text] [Related]
33. Synthetic glycopeptides from the mucin family as potential tools in cancer immunotherapy.
Becker T; Dziadek S; Wittrock S; Kunz H
Curr Cancer Drug Targets; 2006 Sep; 6(6):491-517. PubMed ID: 17017874
[TBL] [Abstract][Full Text] [Related]
34. Chemoenzymatic synthesis of a MUC1 glycopeptide carrying non-natural sialyl TF-beta O-glycan.
Tanaka E; Nakahara Y; Kuroda Y; Takano Y; Kojima N; Hojo H; Nakahara Y
Biosci Biotechnol Biochem; 2006 Oct; 70(10):2515-22. PubMed ID: 17031043
[TBL] [Abstract][Full Text] [Related]
35. Carbohydrate antigens on cancer-associated mucin-like molecules.
Ho SB; Kim YS
Semin Cancer Biol; 1991 Dec; 2(6):389-400. PubMed ID: 1725730
[TBL] [Abstract][Full Text] [Related]
36. Combinatorial synthesis of MUC1 glycopeptides: polymer blotting facilitates chemical and enzymatic synthesis of highly complicated mucin glycopeptides.
Fumoto M; Hinou H; Ohta T; Ito T; Yamada K; Takimoto A; Kondo H; Shimizu H; Inazu T; Nakahara Y; Nishimura S
J Am Chem Soc; 2005 Aug; 127(33):11804-18. PubMed ID: 16104759
[TBL] [Abstract][Full Text] [Related]
37. Design of a MUC1-based cancer vaccine.
Hanisch FG
Biochem Soc Trans; 2005 Aug; 33(Pt 4):705-8. PubMed ID: 16042579
[TBL] [Abstract][Full Text] [Related]
38. A fully synthetic four-component antitumor vaccine consisting of a mucin glycopeptide antigen combined with three different T-helper-cell epitopes.
Palitzsch B; Hartmann S; Stergiou N; Glaffig M; Schmitt E; Kunz H
Angew Chem Int Ed Engl; 2014 Dec; 53(51):14245-9. PubMed ID: 25318465
[TBL] [Abstract][Full Text] [Related]
39. Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone.
Seo KY; Chung SH; Lee JH; Park MY; Kim EK
Cornea; 2007 Jul; 26(6):709-14. PubMed ID: 17592322
[TBL] [Abstract][Full Text] [Related]
40. T cells recognize PD(N/T)R motif common in a variable number of tandem repeat and degenerate repeat sequences of MUC1.
Pisarev VM; Kinarsky L; Caffrey T; Hanisch FG; Sanderson S; Hollingsworth MA; Sherman S
Int Immunopharmacol; 2005 Feb; 5(2):315-30. PubMed ID: 15652762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
